Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126437131 | 12643713 | 1 | I | 20160707 | 20160811 | 20160811 | EXP | JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-121992 | RANBAXY | 0.00 | F | Y | 48.00000 | KG | 20160811 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126437131 | 12643713 | 1 | PS | OXALIPLATIN. | OXALIPLATIN | 1 | Unknown | 85 MG/M2, DAY 1 | U | U | 202922 | 85 | MG/M**2 | ||||||
| 126437131 | 12643713 | 2 | SS | 5-fluorouracil | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 400 MG/M2, QUICK INFUSION DAY 1 | U | U | 0 | 400 | MG/M**2 | ||||||
| 126437131 | 12643713 | 3 | SS | 5-fluorouracil | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 2400 MG/M2, CONTINUOUS INFUSION FOR 46 HOURS EVERY 14 DAYS | U | U | 0 | 2400 | MG/M**2 | ||||||
| 126437131 | 12643713 | 4 | SS | Calcium folinat | LEUCOVORIN CALCIUM | 1 | Intravenous (not otherwise specified) | 200 MG/M2, DAY 1 | U | U | 0 | 200 | MG/M**2 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126437131 | 12643713 | 1 | Small intestine carcinoma metastatic |
| 126437131 | 12643713 | 2 | Small intestine carcinoma metastatic |
| 126437131 | 12643713 | 4 | Small intestine carcinoma metastatic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126437131 | 12643713 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126437131 | 12643713 | Neurotoxicity | |
| 126437131 | 12643713 | Neutropenia | |
| 126437131 | 12643713 | Pigmentation disorder | |
| 126437131 | 12643713 | Therapeutic response decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |